Skip to main content
2888 search results for:

Ticagrelor 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Ticagrelor | News

    Ticagrelor

    Ticagrelor induced acute onset dyspnoea
  2. 26-04-2024 | Acute Coronary Syndrome | News | Article
    ACC 2024

    Ticagrelor reduces bleeding risk post-stenting

    Ticagrelor monotherapy is associated with a reduced risk for bleeding in patients with ACS after PCI than those receiving ticagrelor plus aspirin.

  3. 01-04-2024 | Pulmonary Hemorrhage | News

    Ticagrelor

    Pulmonary haemorrhage
  4. Open Access 13-05-2024 | Ticagrelor | Online First

    Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel

    The percutaneous coronary intervention (PCI) has shown great advancement both in terms of safety and efficacy in the contemporary era [ 1 , 2 ]. Notwithstanding this, the number of readmissions for repeat revascularization following index PCI …

  5. 01-04-2024 | Ticagrelor | News

    Ticagrelor

    Cheyne-stokes respiration and asystolic ventricular standstill
  6. Open Access 01-12-2024 | Ticagrelor | OriginalPaper

    Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials

    Cardiovascular disease (CVD) is one among the major causes of mortality all round the globe [ 1 ]. Several anti-platelet regimens have been proposed following percutaneous coronary intervention (PCI) [ 2 ]. Since platelet hyperactivity is more …

  7. 01-03-2024 | Ticagrelor | News

    Ticagrelor

    Upper gastrointestinal bleeding
  8. 01-03-2024 | Ticagrelor | News

    Ticagrelor

    Dyspnoea with respiratory alkalosis
  9. 01-03-2024 | Ticagrelor | News

    Ticagrelor

    Various toxicities secondary to drug toxicity following an intentional overdose of ticagrelor
  10. Open Access 15-04-2024 | Ticagrelor | OriginalPaper

    Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial

    Large-vessel occlusion (LVO) ischemic stroke represents about 25–40% of all ischemic strokes, and it raises the mortality risk by more than double when compared with non-LVO stroke [ 1 , 2 ]. The term LVO is used when there is a blockage of the …

  11. 31-03-2024 | Prasugrel | OriginalPaper

    Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome

    Low-dose prasugrel demonstrated a similar effectiveness profile to clopidogrel in East Asian ACS patients, but its comparison with another new-generation potent P2Y12 inhibitor, ticagrelor, remains unclear. To compare the effectiveness and safety …

  12. 05-04-2024 | Ticagrelor | Online First

    Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis

    The risk of a subsequent stroke preceded by a minor stroke or transient ischemic attacks (TIA) after 90 days of the initial event ranges from 10 to 20% [ 1 , 2 ]. According to the last revised guidelines from the American Heart Association (AHA) …

  13. 01-04-2024 | Ticagrelor | ReviewPaper

    Safety of Clopidogrel vs. Ticagrelor in Dual Antiplatelet Therapy Regimens for High-Bleeding Risk Acute Coronary Syndrome Patients: A Comprehensive Meta-analysis of Adverse Outcomes

    Cardiovascular diseases (CVDs) significantly contribute to disease burden worldwide, accounting for approximately a third of total deaths annually [ 1 ]. A serious and prevalent CVD, Acute Coronary Syndrome (ACS), having a dramatic rise in …

  14. 01-02-2024 | Ticagrelor | News

    Statin and ticagrelor drug interaction increases risk of rhabdomyolysis

  15. 25-01-2024 | Acute Coronary Syndrome | Letter

    Comment on: “Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study”

  16. Open Access 01-12-2024 | Ticagrelor | ReviewPaper

    Progress in the clinical effects and adverse reactions of ticagrelor

    Since its approval in 2010, ticagrelor has been widely used as an antiplatelet agent for the treatment of clinical acute coronary syndrome (ACS). Ticagrelor is a novel P2Y12 receptor antagonist that is rapidly absorbed by the body after oral …

  17. 07-02-2024 | Ticagrelor | OriginalPaper

    Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia

    Acute coronary syndrome (ACS) is characterized by a sudden reduction of blood supply to the heart, most often caused by coronary atherosclerotic plaque rupture and thrombus formation [ 1 ]. Percutaneous coronary intervention (PCI) and dual …

  18. 25-01-2024 | Ticagrelor | Letter

    Author’s Reply to Kow et al.: “Comparison of Clinical Outcomes between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study”

  19. Open Access 30-09-2023 | Ticagrelor | OriginalPaper

    Ticagrelor was associated with lower fracture risk than clopidogrel in the dual anti-platelet regimen among patients with acute coronary syndrome treated with percutaneous coronary intervention

    Osteoporosis is a global pandemic. It is clinically silent until complications occur, manifesting as fragility fractures [ 1 ]. Hip and vertebral fractures are the more devastating types of fragility fractures associated with significant …

  20. Open Access 01-12-2024 | Intravascular Ultrasound | OriginalPaper

    Effect of ticagrelor versus clopidogrel after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome—propensity score matching analysis

    Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is the cornerstone anti-thrombosis treatment for patients with acute coronary syndrome (ACS) who undergo stent implantation.Although the more potent P2Y12 inhibitor, ticagrelor

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.